AstraZeneca in the UK
A global pharmaceutical company with a major UK presence. Our purpose is to push the boundaries of science to deliver life-changing medicines. The best way we can help patients is to be science-led and share this passion with the scientific, healthcare and business communities of the UK.
Our contribution to the UK
Our UK sites
Scroll through the locations below to find out more about our sites in the UK.
The Cambridge site will become our largest centre for oncology research worldwide. Beyond cancer research, our R&D will focus on cardiovascular and metabolic diseases, respiratory, inflammation and autoimmune diseases and conditions of the central nervous system. The site will bring together our small molecule and biologics R&D, opening up opportunities to exploit the promise of small and large molecule combinations. Additionally, we will have medicinal chemistry, high-throughput screening and cellular and molecular biology, as well as clinical development and pre-clinical research capabilities located on the site.Find out more
Alderley Park, Cheshire
Employing approximately 2,900 people, including some of the world’s most skilled and experienced science professionals, Alderley Park is renowned for the discovery and development of innovative new medicines. As the lead centre for cancer research, Alderley Park currently houses the global Advanced Lead Discovery Centre, which includes innovative facilities to assist with the drug discovery process, in addition to oncology discovery and early development capabilities (Oncology Innovative Medicines). Alderley Park is also home to employees within our global medicines development function, who are responsible for the late stage development of our pipeline (products in phase III development).
AstraZeneca’s UK Marketing Company (UKMC) is a part of our global commercial organisation, and is responsible for the marketing of our medicines in the UK. The UKMC’s base at Horizon Place is also home to colleagues from AstraZeneca’s corporate functions and our European and international regions’ sales and marketing teams (the latter includes markets in Latin America, the Middle East & Africa, Asia, and Australasia).
Macclesfield, in the north-west of England, is our second largest manufacturing site and our European centre for packing. Some 1,800 people are employed at our Macclesfield site, where we manufacture, pack and distribute our medicines to 130 global markets. Effective manufacturing processes are vitally important to our work, so we’ve introduced new techniques at Macclesfield which have increased efficiency significantly.
At Speke, near Liverpool, our biologics team plays a vital role in the UK's child flu vaccination programme, developing new vaccines each year to combat fresh strains and mutations.
Who we work with
Grants and Donations
AstraZeneca UK aims to support local innovation and best practice that improves patient care in Respiratory, Immunology, Cardiovascular, Metabolic, Renal and Oncology therapy areas. Grants and Donations may be awarded to Healthcare Organisations, Patient Organisations, or Charities involved in patient support. The Grants & Donations process does not accept Externally Sponsored Research or Product Donation requests (they are reviewed via alternative processes)..
Please review the definitions below and apply for the appropriate type of external funding by clicking the link and completing a request in the CyberGrants tool.
- Once you have submitted your completed form, your request will be reviewed by committee. The total review time can be up to 10-12 weeks, therefore please allow sufficient time to apply before the proposed project/activity start date. We will contact you by email with the outcome.
- Should your application be successful, a member of the AstraZeneca UK Medical and Scientific Affairs team will periodically be reaching out to you to confirm progress of the project at appropriate timely intervals.
Grants & Donations are provided by AstraZeneca without intent or agreement for AstraZeneca to receive any benefit in exchange (a mere display of the AstraZeneca logo or name is not considered a benefit).
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.
VVPM ID: GB-24861 Date of Prep: November 2020